Multimodal therapy and use of adjunctive therapies to BoNT-A in spasticity management: defining terminology to help enhance spasticity treatment
Rajiv Reebye(University of British Columbia), Gerard E. Francisco(Memorial Hermann Institute for Rehabilitation and Research Foundation), Nathalie Draulans(Libra Revalidatie & Audiologie), Alessandro Picelli(University of Verona), Monica Verduzco‐Gutierrez(The University of Texas Health Science Center at San Antonio), Andrea Santamato(University of Foggia), Bo Biering‐Sørensen(Copenhagen University Hospital), Michael W. O’Dell(Cornell University), Franco Molteni(Bambino Gesù Children's Hospital), Heather W. Walker(University of North Carolina at Chapel Hill), Stefano Carda(University Hospital of Lausanne), Joerg Wissel(University of Potsdam), Alexander Balbert
Cited by 25
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial
|The Lancet Neurology|2015|213
Introduction and Methodology: <i>Standards of Care in Diabetes—2024</i>
|Diabetes Care|2023|184
Rehabilitation procedures in the management of spasticity.
|PubMed|2010|168